Journal of Neurogastroenterology and Motility
Overview
The Journal of Neurogastroenterology and Motility is a peer-reviewed scientific journal that focuses on the study of the nervous system and its impact on gastrointestinal function and motility. It publishes original research articles, reviews, and clinical studies, providing valuable insights into the complex interplay between the brain, gut, and their disorders.
Details
Details
Abbr.
J Neurogastroenterol Motil
Start
2010
End
Continuing
Frequency
Quarterly
p-ISSN
2093-0879
e-ISSN
2093-0887
Country
South Korea
Language
English
Metrics
Metrics
h-index / Ranks: 6023
61
SJR / Ranks: 4192
944
CiteScore / Ranks: 2975
6.90
JIF / Ranks: 2884
3.4
Recent Articles
1.
Jung D, Youn Y, Jung H, Lee K
J Neurogastroenterol Motil
. 2025 Jan;
31(1):119-128.
PMID: 39779209
Background/aims: Serum gastrin levels may be elevated following proton pump inhibitor (PPI) therapy. We aim to elucidate the predictors for the development of hypergastrinemia in maintenance treatment for mild gastroesophageal...
2.
Sanchez R, Reichard E, Bobbey A, Bali Puri N, Lu P, Yacob D, et al.
J Neurogastroenterol Motil
. 2025 Jan;
31(1):102-109.
PMID: 39779208
Background/aims: Pediatric patients with suspected gastroparesis often undergo antroduodenal manometry (ADM) and gastric emptying scintigraphy (GES) for diagnostic purposes. However, it is unknown if delayed gastric emptying (DGE) correlates with...
3.
Felix-Tellez F, Cruz-Salgado A, Remes-Troche J, Flores-Rendon A, Ordaz-Alvarez H, Velasco J, et al.
J Neurogastroenterol Motil
. 2025 Jan;
31(1):95-101.
PMID: 39779207
Background/aims: This study aims to investigate the association between Binge Eating Disorder and functional dyspepsia in a Mexican population, focusing on symptomatology and demographic characteristics. Methods: We conducted a cross-sectional...
4.
Chen C, Chou C, Yuan M, Tsai K, Wu J, Liao W, et al.
J Neurogastroenterol Motil
. 2025 Jan;
31(1):75-85.
PMID: 39779206
Background/aims: Anti-reflux mucosal ablation (ARMA) is a promising endoscopic intervention for proton pump inhibitor (PPI)-dependent gastroesophageal reflux disease (GERD). However, the effect of ARMA on esophageal motility remains unclear. Methods:...
5.
Wang Y, Wang C, Chuang C, Tsou Y, Peng Y, Chang C, et al.
J Neurogastroenterol Motil
. 2025 Jan;
31(1):63-74.
PMID: 39779205
Background/aims: Distal mean nocturnal baseline impedance (MNBI) measuring via pH-impedance may be valuable in diagnosing patients with suspected laryngopharyngeal reflux (LPR). However, its wide adoption is hindered by cost and...
6.
Kim N, Chang Y, Ryu S, Sohn C
J Neurogastroenterol Motil
. 2025 Jan;
31(1):54-62.
PMID: 39779204
Background/aims: We aim to compare the remission of erosive esophagitis (EE) among individuals with different phenotypes based on their metabolic health and obesity status and investigate the impact of changes...
7.
Stanton M, Pandolfino J, Simlote A, Kahrilas P, Carlson D
J Neurogastroenterol Motil
. 2025 Jan;
31(1):45-53.
PMID: 39779203
Background/aims: Functional lumen imaging probe (FLIP) Panometry has demonstrated utility in the assessment of esophageal motility as a complement to existing methodologies like high-resolution manometry. However, as FLIP is typically...
8.
Li T, Codipilly D, Snyder D, Ravi K, Pang M, Koop A
J Neurogastroenterol Motil
. 2025 Jan;
31(1):38-44.
PMID: 39779202
Background/aims: Multiple rapid swallows (MRS) is a provocative test during high-resolution esophageal manometry (HRM) to evaluate contraction reserve (CR). This study aims to determine the prevalence of CR in patients...
9.
Iqbal M, Hira S, Saeed H, Shahid S, Butt S, Rashid K, et al.
J Neurogastroenterol Motil
. 2025 Jan;
31(1):28-37.
PMID: 39779201
Background/aims: Amitriptyline is prescribed off-label for irritable bowel syndrome (IBS). We conducted a meta-analysis to assess its efficacy. Methods: A systematic literature review was conducted until November 10, 2023, using...
10.
Mohamedali Z, Amarasinghe G, Hopkins C, Moulton C
J Neurogastroenterol Motil
. 2025 Jan;
31(1):18-27.
PMID: 39779200
Background/aims: Buspirone shows promise in treating disorders of gut-brain interaction (DGBIs), particularly functional dyspepsia. However, findings have been mixed. Methods: We systematically searched for prospective studies testing buspirone for any...